Data / Form D filings / Gossamer Bio, Inc.
Gossamer Bio, Inc.: Form D filings
Gossamer Bio, Inc., a biotechnology company in San Diego, CA, filed 6 Form D notices with the SEC between 2018 and 2026. The latest, on September 4, 2026, reports $25 million sold of a $150 million offering to 38 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3115 Merryfield Row, Suite 120, San Diego, CA, 92121
- Phone
- (858) 684-1300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1728117
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | New notice | $150,000,000 | $25,000,000 | $125,000,000 | 38 | Aug 20, 2026 | sec.gov |
| Aug 7, 2023 | New notice | $212,102,057 | $212,102,057 | 70 | Jul 24, 2023 | sec.gov | |
| Jul 18, 2022 | New notice | $120,041,922 | $120,041,922 | 23 | Jul 15, 2022 | sec.gov | |
| Aug 1, 2018 | New notice | $230,015,000 | $230,015,000 | 67 | Jul 20, 2018 | sec.gov | |
| Jan 19, 2018 | New notice | $80,000,000 | $70,468,084 | $9,531,916 | 3 | Jan 4, 2018 | sec.gov |
| Jan 19, 2018 | New notice | $80,000,000 | $70,468,084 | $9,531,916 | 3 | Jan 4, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Faheem Hasnain | Executive Officer, Director | |
| Russell Cox | Director | |
| Thomas Daniel | Director | |
| Skye J. Drynan | Director | |
| Sandra Milligan | Director | |
| Steven D. Nathan | Director | |
| John Quisel | Director | |
| Bryan Giraudo | Executive Officer | |
| Christian Waage | Executive Officer | |
| Robert Smith | Executive Officer | |
| Caryn Peterson | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 31, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gossamer Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.